Latest Insider Transactions at Inhibitor Therapeutics, Inc. (INTI)
This section provides a real-time view of insider transactions for Inhibitor Therapeutics, Inc. (INTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inhibitor Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inhibitor Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2024
|
Ronald E Osman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
50,000
+0.21%
|
-
|
|
Apr 01
2024
|
Samuel P Sears Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+4.24%
|
-
|
|
Apr 01
2024
|
Michelle Yanez Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.28%
|
-
|
|
Apr 01
2024
|
Michael Allen Jerman Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.34%
|
-
|
|
Aug 11
2023
|
Ronald E Osman Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+0.11%
|
-
|
|
May 05
2023
|
James A Mcnulty CHIEF FINANCIAL OFFICER |
BUY
Other acquisition or disposition
|
Indirect |
20,101,057
+43.51%
|
-
|
|
May 05
2023
|
James A Mcnulty CHIEF FINANCIAL OFFICER |
BUY
Other acquisition or disposition
|
Direct |
398,135
+29.62%
|
-
|
|
May 05
2023
|
James A Mcnulty CHIEF FINANCIAL OFFICER |
SELL
Other acquisition or disposition
|
Indirect |
79,627,069
-100.0%
|
-
|
|
May 05
2023
|
Michelle Yanez Director |
BUY
Other acquisition or disposition
|
Direct |
796,271
+49.86%
|
-
|
|
Jan 15
2021
|
Mayne Pharma Ventures Pty LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
2,240,488
+1.09%
|
-
|